摘要
动脉粥样硬化是由炎症驱动的,具有强大的先天免疫的参与,并涉及到一个扩展的动脉内膜,通常是小面积的几个细胞类型,包括平滑肌细胞,脂质,单核细胞,巨噬细胞,树突状细胞和细胞外基质。来自聚集单核细胞的巨噬细胞是主要的先天免疫细胞,在动脉粥样硬化病变的形成中起着至关重要的作用。人类动脉粥样硬化斑块显示斑块内的巨噬细胞亚群可能更有用,解释斑块的表型,而不仅仅是简单地给巨噬细胞的总数。因此,认识到巨噬细胞亚群在动脉粥样硬化斑块形成,进展和回归的作用将是最有帮助的识别新的战略,以稳定或减轻动脉粥样硬化病变。本文综述了巨噬细胞亚群的影响及其在动脉粥样硬化中的作用。
关键词: 动脉粥样硬化,先天免疫,Toll样受体,巨噬细胞,巨噬细胞极化,氧化低密度脂蛋白。
Current Medicinal Chemistry
Title:Impact of Macrophages in Atherosclerosis
Volume: 23 Issue: 18
Author(s): Xinjie Lu
Affiliation:
关键词: 动脉粥样硬化,先天免疫,Toll样受体,巨噬细胞,巨噬细胞极化,氧化低密度脂蛋白。
摘要: Atherosclerosis is driven by inflammation, with a strong involvement of innate immunity, and involves an expansion of the arterial intima, a normally small area composed of several cell types including smooth muscle cells, lipids, monocytes, macrophages, dendritic cells, and extracellular matrix. Macrophages derived from recruited monocytes are predominant innate immune cells that play crucial roles in the formation of atherosclerotic lesions. Human atherosclerotic plaques have shown that macrophage subsets within a plaque might be more useful for explaining plaque phenotype than just simply giving the total number of macrophages. Therefore, recognizing the roles of macrophage subsets in atherosclerotic plaque formation, progression, and regression would be most helpful for identification of novel strategies to stabilize, or attenuate atherosclerotic lesions. This review discusses the impact of macrophage subsets and their roles in atherosclerosis.
Export Options
About this article
Cite this article as:
Xinjie Lu , Impact of Macrophages in Atherosclerosis, Current Medicinal Chemistry 2016; 23 (18) . https://dx.doi.org/10.2174/0929867323666160428105111
DOI https://dx.doi.org/10.2174/0929867323666160428105111 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Streptokinase: An Efficient Enzyme in Cardiac Medicine
Protein & Peptide Letters Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery The Therapeutical Effect of Chinese Medicine for the Treatment of Atherosclerotic Coronary Heart Disease
Current Pharmaceutical Design Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death
Current Pharmaceutical Biotechnology Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Use of Chronic Disease Registries to Optimize Cardiovascular Health
Current Vascular Pharmacology Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain
Endocrine, Metabolic & Immune Disorders - Drug Targets New Insights into the Pleiotropic Effects of Statins for Stroke Prevention
Mini-Reviews in Medicinal Chemistry Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management
Current Vascular Pharmacology Second-Generation Antipsychotic Agents: A Review of Safety Profiles
Current Psychiatry Reviews Nanotechnology and Atherosclerosis Imaging: Emerging Diagnostic and Therapeutic Applications
Recent Patents on Cardiovascular Drug Discovery Dyslipidaemia Related to Insulin Resistance and Cardiovascular Disease in South Asian and West African Populations
Current Pharmaceutical Design Limited Hypotensive Effect of Sildenafil in a High-Risk Population: A Preliminary Report
Current Drug Safety Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling
Current Drug Targets Boundaries and Overlap between Hypochondriasis and Other Disorders: Differential Diagnosis and Patterns of Co-occurrence
Current Psychiatry Reviews Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs
Cardiovascular & Hematological Disorders-Drug Targets Metabolomics
Current Drug Metabolism Radiation-Induced Extracranial Carotid Stenosis
Vascular Disease Prevention (Discontinued)